Evidence map›Paper›PMID 34249620›Full record

ArticleAnnals of global health2021

Using Artificial Intelligence for High-Volume Identification of Silicosis and Tuberculosis: A Bio-Ethics Approach.

Jerry M Spiegel, Rodney Ehrlich, Annalee Yassi, Francisco Riera, James Wilkinson, Karen Lockhart, Stephen Barker, Barry Kistnasamy

Open access · goldAbstract read
In one paragraph

Article in Annals of global health, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
0.6field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 4 countries.

Jerry M SpiegelSchool of Population and Public Health, The University of British Columbia, Vancouver, BC, Canada.ORCID 0000-0002-4699-3082
Rodney EhrlichSchool of Public Health and Family Medicine, University of Cape Town, Cape Town, South Africa.ORCID 0000-0001-5736-9237
Annalee YassiSchool of Population and Public Health, The University of British Columbia, Vancouver, BC, Canada.ORCID 0000-0001-9103-4051
Francisco RieraIMC Worldwide Inc., London, UK.
James WilkinsonBrink, London, UK.
Karen LockhartSchool of Population and Public Health, The University of British Columbia, Vancouver, BC, Canada.ORCID 0000-0002-0296-5661
Stephen BarkerSchool of Population and Public Health, The University of British Columbia, Vancouver, BC, Canada.
Barry KistnasamyNational Department of Health, Johannesburg, South Africa.
University of British Columbia · CAAIR Worldwide (United Kingdom) · GBNational Department of Health · PGUniversity of Cape Town · ZA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Although Artificial Intelligence (AI) is being increasingly applied, considerable distrust about introducing "disruptive" technologies persists. Intrinsic and contextual factors influencing where and how such innovations are introduced therefore require careful scrutiny to ensure that health equity is promoted. To illustrate one such critical approach, we describe and appraise an AI application - the development of computer assisted diagnosis (CAD) to support more efficient adjudication of compensation claims from former gold miners with occupational lung disease in Southern Africa. In doing so, we apply a bio-ethical lens that considers the principles of beneficence, non-maleficence, autonomy and justice and add explicability as a core principle. We draw on the AI literature, our research on CAD validation and process efficiency, as well as apprehensions of users and stakeholders. Issues of concern included AI accuracy, biased training of AI systems, data privacy, impact on human skill development, transparency and accountability in AI use, as well as intellectual property ownership. We discuss ways in which each of these potential obstacles to successful use of CAD could be mitigated. We conclude that efforts to overcoming technical challenges in applying AI must be accompanied from the onset by attention to ensuring its ethical use.

Indexed as

Artificial IntelligenceBioethical IssuesSilicosisTuberculosisDelivery of Health CareHumansSocial Justice

Identifiers

PMID34249620
PMCPMC8252970
OpenAlexW3177817367

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.